'Decorated' stem cells could offer targeted heart repair

January 10, 2018 by Tracey Peake, North Carolina State University
Cardiac stem cells (magenta) are decorated with platelet vesicles (brown). Credit: NC State University

Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal model, North Carolina State University researcher Ke Cheng and his team show that "decorating" cardiac stem cells with platelet nanovesicles can increase the stem cells' ability to find and remain at the site of heart attack injury and enhance their effectiveness in treatment.

"Platelets can home in on an site and stay there, and even in some cases recruit a body's own naturally occurring stem to the site, but they are a double-edged sword," says Cheng, associate professor of veterinary medicine and associate professor in the NC State/UNC Joint Department of Biomedical Engineering. "That's because once the platelets arrive at the site of injury, they trigger the coagulation processes that cause clotting. In a injury, blood clots are the last thing that you want."

Cheng and his associates wondered if it would be possible to co-opt a platelet's ability to locate and stick to an injury site without inducing clotting. They found that adhesion molecules (a group of glycoproteins) located on the platelet's surface were responsible for its ability to find and bind to an injury. So the team created platelet nanovesicles from these molecules, and then decorated the surface of with the nanovesicles,

"The nanovesicle is like the platelet's coat," Cheng says. "There isn't any internal cellular machinery that could activate clotting. When you place the nanovesicle on the stem cell, it's like giving the stem cell a tiny GPS that helps it locate the injury so it can do its repair work without any of the side effects associated with live platelets."

In a proof-of-concept study involving a rat model of myocardial infarction, twice as many platelet nanovesicle decorated cardiac stem cells, or PNV-CSCs, were retained in the heart than non-decorated cardiac stem cells. The rodents were monitored for four weeks. Overall, the rats in the PNV-CSC group showed nearly 20 percent or higher cardiac function than the control CSC group.

A small pilot study in a pig model also demonstrated higher rates of stem cell retention with PNV-CSCs, though the team did not perform functional studies. A future follow-up study is planned.

"Platelet nanovesicles do not affect the performance of the cardiac stem cells, and are free from any negative side effects," Cheng says. "Hopefully we will be able to use this approach to improve cardiac in clinical trials in the future."

The work appears in Nature Biomedical Engineering.

Explore further: Cellular hitchhikers aid recovery from spinal cord injury

More information: Junnan Tang et al, Targeted repair of heart injury by stem cells fused with platelet nanovesicles, Nature Biomedical Engineering (2018). DOI: 10.1038/s41551-017-0182-x

Related Stories

Cellular hitchhikers aid recovery from spinal cord injury

January 8, 2018
The healing effects of stem cells in spinal cord injury can be aided by their ability to hitch intercellular rides to specific anti-inflammatory cells called M2 macrophages, Yale researchers report.

An attractive solution for heart repair

August 15, 2014
Stem cell therapy is a promising option for repairing heart tissue damaged by heart attack. However, the main obstacle to cardiac stem cell therapy also happens to be pretty difficult to get around – and that's the fact ...

Synthetic stem cells could offer therapeutic benefits, reduced risks

December 26, 2016
Researchers from North Carolina State University, the University of North Carolina at Chapel Hill and First Affiliated Hospital of Zhengzhou University have developed a synthetic version of a cardiac stem cell. These synthetic ...

Cardiac stem cells from heart disease patients may be harmful

June 15, 2017
Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and "miraculous" stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, ...

Using donor stem cells to treat spinal cord injury

August 28, 2017
A new study in mice published in The Journal of Neuroscience details a potential therapeutic strategy that uses stem cells to promote recovery of motor activity after spinal cord injury.

Recommended for you

Human 'chimeric' cells restore crucial protein in Duchenne muscular dystrophy

March 16, 2018
Cells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne muscular dystrophy —a rare but fatal form of muscular dystrophy—were able to significantly improve muscle function when implanted ...

Team develops 3-D tissue model of a developing human heart

March 16, 2018
The heart is the first organ to develop in the womb and the first cause of concern for many parents.

Democratizing science: Researchers make neuroscience experiments easier to share, reproduce

March 16, 2018
Over the past few years, scientists have faced a problem: They often cannot reproduce the results of experiments done by themselves or their peers.

Genetic variant discovery to help asthma sufferers

March 16, 2018
Research from the University of Liverpool, published today in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range ...

Researchers say use of artificial intelligence in medicine raises ethical questions

March 15, 2018
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.

Study identifies potential drug for treatment of debilitating inherited neurological disease

March 15, 2018
St. Jude Children's Research Hospital scientists have demonstrated in mouse studies that the neurological disease spinal bulbar muscular atrophy (SBMA) can be successfully treated with drugs. The finding paves the way for ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.